EGFR Inhibitor Poised to Change Practice in NSCLC

Drs. Mark Kris and Luis Paz-Ares highlight lung cancer presentations from ASCO 2014, including a promising agent in squamous cell and a new EGFR-TKI that overcomes resistance and may change practice.

http://www.medscape.com/viewarticle/826969

Source: Medscape Oncology - June 19, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma